Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is in the following collections:

COVID-19 Community

Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid) Open Access (recommended)

Abu-Raya B, Migliori GB, O'Ryan M, Edwards K, Torres A, Alffenaar JW, Martson AG, Centis R, D'Ambrosio L, Flanagan K, Hung I, Lauretani F, Leung CC, Leuridan E, Maertens K, Maggio MG, Nadel S, Hens N, Niesters H, Osterhaus A, Pontali E, Principi N, Silva DR, Omer S, Spanevello A, Sverzellati N, Tan TN, Torres-Torreti JP, Visca D, Esposito S. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Frontiers in Medicine. 2020;7:20.

Descriptions

Resource type(s)
Review
Keyword
COVID-19
coronavirus
intensive care management
prevention
workplace safety
infection control
SARS-CoV-2
physical distancing
Rights
Attribution 4.0 International

Creator
Abu-Raya, Bahaa
Migliori, Giovanni Battista
O'Ryan, Miguel
Edwards, Kathryn
Torres, Antoni
Alffenaar, Jan-Willem
Martson, Anne-Grete
Centis, Rosella
D'Ambrosio, Lia
Flanagan, Katie
Hung, Ivan
Lauretani, Fulvio
Leung, Chi Chi
Leuridan, Elke
Maertens, Kirsten
Maggio, Marcello Giuseppe
Nadel, Simon
Hens, Niel
Niesters, Hubert
Osterhaus, Albert
Pontali, Emanuele
Principi, Nicola
Rossato Silva, Denise
Omer, Saad
Spanevello, Antonio
Sverzellati, Nicola
Tan, Tina Quanbee
Torres-Torreti, Juan Pablo
Visca, Dina
Esposito, Susanna
Abstract
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
Related URL
Publisher
FRONTIERS MEDIA SA
Date Created
2020-10-30
Original Identifier
(PMID) 33195319
Grants and funding
Marie Sklodowska-Curie Actions [529 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015]; IDIBAPS; CIBERES; ICREAICREA
DOI
10.3389/fmed.2020.572485

File Details

File Properties
Mime type: application/pdf
File size: 1825.8 kB